Bayer acquires BlueRock Therapeutics to build leading position in cell therapy

Drug Discovery |  News | 0 Comment | 14 Aug, 2019

Bayer AG and BlueRock Therapeutics hasannounced an agreement under which Bayer will fully acquire BlueRock Therapeutics, a privately held US-headquartered biotechnology company focused on d...Read more

Sun Pharma announces regulatory filing of Tildrakizumab in Japan

Drug Discovery |  News | 0 Comment | 01 Aug, 2019

Sun Pharmaceutical Industries Ltd. has announced that one of its wholly owned subsidiaries has filed an application for Manufacturing and Marketing Authorization of Tildrakizumab for modera...Read more

Pfizer completes acquisition of Array Biopharma

Drug Discovery |  News | 0 Comment | 31 Jul, 2019

Pfizer Inc.  announced the successful completion of its acquisition of Array BioPharma Inc., advancing breakthrough science for the discovery, development and commercialization of targ...Read more

3SBio to bring first self-developed pre-filled fusion protein injection solution

Drug Discovery |  News | 0 Comment | 30 Jul, 2019

3SBio Inc., a leading biopharmaceutical company in the People's Republic of China (PRC) has announced that an application for the production of new drug has been submitted to the National M...Read more

AstraZeneca’s roxadustat reveals positive results against anaemia

Drug Discovery |  News | 0 Comment | 25 Jul, 2019

AstraZeneca has announced that data from two Phase III trials evaluating the efficacy and safety of roxadustat in China. The trials, Study 806 and 808, evaluated roxadustat in Chinese pati...Read more

Sosei Heptares teams up with Genentech for multi-target R&D

Drug Discovery |  News | 0 Comment | 17 Jul, 2019

Japan headquartered Sosei Group Corporation has entered into a multi-target research collaboration and license agreement with Genentech, a member of the Roche Group, to discover and develop...Read more

Eisai collaborates with University of Dundee for cancer drug discovery

Drug Discovery |  News | 0 Comment | 09 Jul, 2019

Japanese pharmaceutical firm Eisai Co.,Ltd. has announced that it has entered into a collaboration research agreement with the University of Dundee in Scotland, UK, regarding Proteolysis Ta...Read more

New Vaccine in the Treatment of Rheumatoid Arthritis

Drug Discovery |  News | 0 Comment | 09 Jul, 2019

CEL-SCI Corporation (NYSE American: CVM) announced that one of its key collaborators from Rush University Medical center, Dr. Adrienn Markovitz an Assistant professor in the depar...Read more

Singapore HSA approves Vosevi to treat Chronic Hepatitis C Virus

Drug Discovery |  News | 0 Comment | 25 Jun, 2019

Gilead Sciences, Inc., on 24 June 2019, announced that the Singapore Health Sciences Authority (HAS) has approved Vosevi (Sofosbuvir 400mg/Velpatasvir 100mg/Voxilaprevir 100mg), a once...Read more

Gilead collaborates with Nurix to develop new cancer therapies

Drug Discovery |  News | 0 Comment | 21 Jun, 2019

Gilead Sciences and Nurix Therapeutics, Inc., have announced a global strategic collaboration to discover, develop and commercialize a pipeline of innovative targeted protein degr...Read more

Zydus’ Nesher Pharma gets final USFDA nod for Lovaza capsules

Drug Discovery |  News | 0 Comment | 17 Jun, 2019

Zydus’ Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA has received the final approval from the USFDA to market Omega-3-Acid Ethyl Esters Capsules USP (US RLD &ndash...Read more

Acucela gets EMA approval for Emixustat to treat Stargardt disease

Drug Discovery |  News | 0 Comment | 11 Jun, 2019

Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), recently announced that th...Read more

Sosei Heptares to receive new $3 million milestone payment from Pfizer

Drug Discovery |  News | 0 Comment | 10 Jun, 2019

Sosei Group Corporation and its strategic alliance partner Pfizer announce that a new clinical candidate from their multi-target drug discovery collaboration was nominated to advance into c...Read more

CStone and Bayer to evaluate PD-L1 monoclonal antibody CS1001 in combination with regorafenib

Drug Discovery |  News | 0 Comment | 10 Jun, 2019

CStone Pharmaceuticals, on 9 June 2019, announced its global clinical collaboration with China focus with Bayer HealthCare LLC to evaluate the safety, tolerability, pharmacokineti...Read more

Luye Pharma's Rykindo gets NDA filing acceptance by USFDA

Drug Discovery |  News | 0 Comment | 30 May, 2019

Rykindo® (LY03004), Luye Pharma's innovative, independently developed Extended-Release Microspheres formulation for injection, is one step closer to going on the U.S...Read more

Sihuan Pharm achieves new grant approval

Drug Discovery |  News | 0 Comment | 28 May, 2019

Sihuan Pharmaceutical Holdings Group Ltd., the largest cardio-cerebral vascular (CCV) drug manufacturer in China's prescription drug market, announced its grant approval for "non-...Read more

BGU introduces Novel Combination Therapy for treating neurological disorders

Drug Discovery |  News | 0 Comment | 13 May, 2019

BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), introduces a novel drug combination therapy, based on two FDA approved drugs, for protecting the ...Read more

Taiwan Health Ministry approves Vemlidy for chronic hepatitis B

Drug Discovery |  News | 0 Comment | 30 Apr, 2019

Gilead Sciences, Inc. has recently announced that with effect from 1 May 2019, Vemlidy (tenofovir alafenamide, TAF) 25 mg, a once-daily treatment for chronic hepatitis B in adults with...Read more